Search hospitals > Maryland > Bethesda
Center For Cancer and Blood Disorders
Claim this profileBethesda, Maryland 20817
Global Leader in Multiple Myeloma
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
151 reported clinical trials
2 medical researchers
Summary
Center For Cancer and Blood Disorders is a medical facility located in Bethesda, Maryland. This center is recognized for care of Multiple Myeloma, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Center For Cancer and Blood Disorders is involved with conducting 151 clinical trials across 116 conditions. There are 2 research doctors associated with this hospital, such as Mark Goldstein, MD and Ralph Boccia.Area of expertise
1Multiple Myeloma
Global Leader2Lung Cancer
Global LeaderStage IV
Stage III
metastatic
Top PIs
Mark Goldstein, MDJEM Research Institute5 years of reported clinical research
Expert in Alzheimer's Disease
Studies Dementia
29 reported clinical trials
46 drugs studied
Ralph BocciaAmerican Oncology Partners of Maryland, PA13 years of reported clinical research
Studies Multiple Myeloma
Studies Breast Cancer
16 reported clinical trials
32 drugs studied
Clinical Trials running at Center For Cancer and Blood Disorders
Multiple Myeloma
Myelofibrosis
Colorectal Cancer
Male Pattern Baldness
Primary Myelofibrosis
Minimal Residual Disease
Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Pancreatic Cancer
Skin Cancer
ABBV-383
for Multiple Myeloma
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can come back (relapsed) or may not get better (refractory) with treatment. This is a study to determine change in disease symptoms of etentamig compared to standard available therapies in adult participants with relapsed/refractory (R/R) MM. Etentamig is an investigational drug being developed for the treatment of R/R MM. This study is broken into 2 Arms; Arm A and Arm B. In Arm A, participants will receive etentamig as a monotherapy. In Arm B, participants will receive the standard available therapy (SAT) identified by the Investigator during screening, in accordance with the local (or applicable) approved label, package insert, summary of product characteristics, and/or the institutional guidelines, as applicable. Around 380 adult participants with relapsed/refractory multiple myeloma will be enrolled at approximately 140 sites across the world. In Arm A participants will receive etentamig as an infusion into the vein in 28 day cycles, during the 3.5 year study duration. In Arm B, participants will receive the SAT identified by the Investigator during screening, in accordance with the local (or applicable) approved label, package insert, summary of product characteristics, and/or the institutional guidelines, as applicable, during the 3.5 year study duration. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and questionnaires.
Recruiting2 awards Phase 34 criteria
Tec-DR and Tal-DR
for Multiple Myeloma
This trial is testing two new drug combinations to see if they work better than the current standard treatment for multiple myeloma. The new treatments aim to help the immune system find and destroy cancer cells more effectively.
Recruiting2 awards Phase 35 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Center For Cancer and Blood Disorders?
Center For Cancer and Blood Disorders is a medical facility located in Bethesda, Maryland. This center is recognized for care of Multiple Myeloma, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Center For Cancer and Blood Disorders is involved with conducting 151 clinical trials across 116 conditions. There are 2 research doctors associated with this hospital, such as Mark Goldstein, MD and Ralph Boccia.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.